Ignite Creation Date:
2025-12-24 @ 5:14 PM
Ignite Modification Date:
2025-12-28 @ 10:48 AM
Study NCT ID:
NCT01719250
Status:
COMPLETED
Last Update Posted:
2018-10-09
First Post:
2012-10-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Sponsor:
Mayo Clinic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-12
Start Date Type:
ACTUAL
Primary Completion Date:
2016-09-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-03-22
Completion Date Type:
ACTUAL
First Submit Date:
2012-10-30
First Submit QC Date:
None
Study First Post Date:
2012-11-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-04
Last Update Post Date:
2018-10-09
Last Update Post Date Type:
ACTUAL